StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) income statement

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.32−0.02 (-1.12%)

Close on Nov 18, 2026Market cap $33.76MP/E –Yield –

BioRestorative Therapies, Inc. income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin
92.1%
Operating margin
-3975.0%
Net margin
-3089.6%
Return on equity, FY2025
-320.5%

Financial strength

Current ratio
2.35
Debt to equity
–
Debt to assets
–
Cash to current liabilities
192.8%

Valuation

P/E ratio
–
Price to sales
94.33
Price to book
11.16
Dividend yield
–

See a number that looks wrong?